Royal Bank Of Canada Has Lowered Expectations for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its target price lowered by analysts at Royal Bank Of Canada from $430.00 to $405.00 in a report issued on Tuesday,Benzinga reports. The firm presently has a “sector perform” rating on the pharmaceutical company’s stock. Royal Bank Of Canada’s price objective would suggest a potential upside of […]
More Stories
Democrat Wins Texas Special Election, Eroding GOP’s Slim House Majority
By Jacob Burg Democrat Christian Menefee prevailed in a special election for a Texas U.S. House seat on Jan. 31,...
Venezuela Plans Amnesty for Political Prisoners, Closure of Notorious Detention Center
By Aldgra Fredly Venezuelan interim leader Delcy Rodríguez on Jan. 30 proposed a general amnesty bill that would lead to...
Wall Street Review: Corporate Earnings Help Support Monthly Stock Gains
By Panos Mourdoukoutas U.S. equities finished mixed in another volatile week but managed to edge higher for the month, supported...
Border Czar Homan Says More Than 145,000 Illegal Immigrant Children Located
By Aldgra Fredly U.S. authorities have located more than 145,000 illegal immigrant children who were previously unaccounted for under the...
Astronauts See Real Connection Between Space Station Work and Moon Missions
By T. J. Muscaro CAPE CANAVERAL, Fla.—For the first time in 60 years, NASA has two crews in quarantine at...
ICE Arrests 650 Illegal Immigrants in West Virginia
By Naveen Athrappully The Immigration and Customs Enforcement (ICE) arrested more than 650 illegal immigrants between Jan. 5 and Jan....